A new molecular imaging radiotracer can precisely diagnose a variety of cancers, providing a roadmap to identify patients who may benefit from targeted radionuclide therapies. In the largest medical study of its kind, researchers ...
Nov 17, 2022
0
49
Despite increased use of telemedicine during the COVID-19 pandemic, Americans have had significantly fewer consultations with primary care doctors and markedly fewer assessments of common cardiac risk factors, according to ...
Oct 2, 2020
0
4
Pfizer and BioNTech said Saturday they will limit the delays of their vaccine deliveries to just one week, after fears in Europe that shipments of the jabs could be slowed for up to a month.
Jan 16, 2021
0
8
Digital twins—virtual doubles of things in the real world—was an idea born in 2002 as a way of looking at the lifespan of products, like space rockets and jet engines, enabling repairs remotely and helping to predict ...
Jun 8, 2022
0
14
The EU announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine.
Jul 31, 2020
0
8
Canada announced deals on Monday with US companies Novavax and Johnson & Johnson for millions doses of their experimental COVID-19 vaccines.
Aug 31, 2020
0
2
The last time Medicare rated hospitals on surgical complications such as bed sores, collapsed lungs, bloodstream infections, and broken hips, four Philadelphia-area facilities scored worse than average.
Jun 16, 2022
0
24
US biotech firm Novavax said Monday it had started clinical trials of its proposed COVID-19 vaccine on children, in a program that will involve up to 3,000 adolescents aged 12-17.
May 3, 2021
0
9
The US has urged states to get ready for a potential COVID-19 vaccine rollout two days before the presidential election, it emerged Wednesday, as France prepared to present a mammoth spending plan for its virus-hit economy.
Sep 3, 2020
0
8
Denmark announced Wednesday that it was revising its targets for COVID-19 vaccinations down by 10 percent in the first quarter due the temporary reduction in deliveries of the Pfizer/BioNTech vaccine in Europe.
Jan 20, 2021
0
3
